LLY announcements Eli Lilly And Company announcements and dividends declared NYSE
Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY
Eli Lilly And Company LLY listed on NYSE and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Eli Lilly And Company LLY
Eli Lilly asks FDA to revoke EUA for COVID antibody treatment alone to speed transition to combination therapy
Eli Lilly and Co. said Friday it is seeking a revocation of the emergency use authorization granted by U.S. regulators for its bamlanivimab antibody treatment for COVID-19 alone in order to complete the transition to bamlanivimab and etesevimab together.
Announcement as on 16 April 2021
Eli Lilly and Incyte say Phase 3 study of baricitinib in hospitalized COVID-19 patients failed to meet main goal
Eli Lilly & Co. and Incyte Corp. said Thursday a Phase 3 trial of rheumatoid arthritis treatment baricitinib plus standard of care (SoC) versus placebo plus SoC failed to meet its main goal. The trial's primary endpoint was defined as a difference in the
Announcement as on 08 April 2021
Eli Lilly, Vir and Glaxo say Phase 2 trial combining antibodies reduced viral load by 70% at day 7
Eli Lilly & Co. , Vir Biotechnology Inc. and GlaxoSmithKline PLC on Monday reported positive data from a Phase 2 trial evaluating the combination of two monoclonal antibodies in treating low-risk adult COVID-19 patients. The trial found combining Lilly'
Announcement as on 29 March 2021
Pfizer, Eli Lilly say experimental arthritis drug tanezumab hits FDA snag
Pfizer Inc. and Eli Lilly and Co. said Thursday that a joint advisory committee of the U.S. Food and Drug Administration has voted against their investigational tanezumab drug for the treatment of certain types of arthritis in adults when use of other d
Announcement as on 25 March 2021
Eli Lilly says U.S. government has agreed to buy at least 100,000 doses of its COVID antibody therapy
Eli Lilly & Co. said Friday the U.S. government has agreed to purchase at least 100,000 doses of its COVID-19 antibody therapy, which was recently granted emergency use authorization for use in recently diagnosed, mild to moderate patients who are at high
Announcement as on 26 February 2021
Announcements by Eli Lilly And Company first page | Next page | Prev page |
LLY Eli Lilly And Company current price & indicator signals
Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 30 Fri Oct 2026 | 1414.92 | 1382.29 to 1449.68 | 3.05% | 1.39 times |
| 29 Thu Oct 2026 | 1373.00 | 1330.00 to 1408.38 | 6.57% | 1.63 times |
| 28 Wed Oct 2026 | 1288.30 | 1260.34 to 1299.43 | 0.53% | 1.14 times |
| 27 Tue Oct 2026 | 1281.52 | 1270.00 to 1297.92 | 0.19% | 0.47 times |
| 26 Mon Oct 2026 | 1279.14 | 1273.73 to 1296.90 | 0.45% | 1.17 times |
| 23 Fri Oct 2026 | 1273.46 | 1257.62 to 1307.92 | -2.55% | 1.27 times |
| 22 Thu Oct 2026 | 1306.74 | 1275.10 to 1321.21 | 2.7% | 0.85 times |
| 21 Wed Oct 2026 | 1272.40 | 1261.08 to 1279.28 | -1.12% | 0.52 times |
| 20 Tue Oct 2026 | 1286.83 | 1260.17 to 1311.75 | 3.62% | 1.19 times |
| 19 Mon Oct 2026 | 1241.82 | 1239.10 to 1259.75 | -1.21% | 0.42 times |
| 16 Fri Oct 2026 | 1257.03 | 1251.25 to 1274.56 | 0.43% | 1.34 times |
| 15 Thu Oct 2026 | 1251.61 | 1230.66 to 1275.88 | 3.55% | 2.09 times |
Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared NYSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance


